COMMUNIQUÉS West-GlobeNewswire

Applied StemCell and Cellipont Bioservices Partner to Offer a Seamless Path for iPSC-Derived Cell Therapy Development
24/03/2026
MILPITAS, Calif. and THE WOODLANDS, Texas, March 24, 2026 (GLOBE NEWSWIRE) -- Applied StemCell, Inc. (“ASC”), a genome engineering company with deep expertise in induced pluripotent stem cell (iPSC) technology and [...]
Callio Therapeutics Doses First Patient in Phase I Clinical Trial of Dual-Payload ADC CLIO-8221 in Advanced HER2-Expressing Solid Tumors
24/03/2026
Callio Therapeutics is actively developing a pipeline of promising dual-payload ADCs featuring rationally designed payload combinations for hard-to-treat tumors CLIO-8221 is the first program from Callio Therapeutics [...]
Addgene and Plasmidsaurus Announce Strategic Partnership to Scale Sequencing for Leading Plasmid Repository
24/03/2026
Strategic partnership to ensure delivery of scalable, cost-effective, and reliable plasmid sequencing as Addgene’s repository expands WATERTOWN, Mass. and SAN FRANCISCO, March 24, 2026 (GLOBE NEWSWIRE) -- Addgene , an [...]
Mineralys Therapeutics Appoints Jeffrey A. Munsie as Chief Legal Officer
24/03/2026
RADNOR, Pa., March 24, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic [...]
Sapu Nano to Launch Deciparticle™ Platform and Present Clinical Pipeline at BIO-Europe Spring 2026
24/03/2026
AGOURA HILLS, Calif., March 24, 2026 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB:OTLC) ("Oncotelic", the "Company" or "We" or “Our”), a leader in RNA-based therapeutics, announced today that its subsidiary [...]
IMUNON to Hold 2025 Financial Results and Business Update Conference Call on Tuesday, March 31, 2026
24/03/2026
LAWRENCEVILLE, N.J., March 24, 2026 (GLOBE NEWSWIRE) -- IMUNON , Inc. (Nasdaq: IMNN) , a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today announced that the Company will host a [...]
Enlivex Announces $21 Million Debt Financing, Decentralized Prediction Markets RAIN Token-Related Updates and $20 Million Share Repurchase Program
24/03/2026
$21 Million debt financing, convertible to ENLV ordinary shares at fixed $2.69175 per share, a 264% premium to the Nasdaq closing price on March 20, 2026, with a single institutional investor The Company exercised an [...]
Harrow Announces Add-On Offering of $50.0 Million of Senior Unsecured Notes to Support Growth
24/03/2026
NASHVILLE, Tenn., March 24, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that it intends to offer, subject to market and [...]
ENvue Medical Expands Presence within a Major Michigan Health System and Grows U.S. Hospital Footprint to 39
24/03/2026
Premier 714-bed teaching hospital and Level I Trauma Center purchases ENvue™ Navigation Platform system and feeding tubes TYLER, Texas, March 24, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc . (NASDAQ: FEED) (“ENvue,” “ [...]
VivoSim Releases Antibody Drug Conjugate (ADC) Data Showing Power to Detect ADC Toxicity and Guide Design of Safer ADCs
24/03/2026
ADCs are a major new market; Company demonstrates ability to discern antibody toxicity from payload toxicity and show differential linker chemistry toxicity SAN DIEGO, March 24, 2026 (GLOBE NEWSWIRE) -- VivoSim Labs, [...]
Press Release Biocartis NV: Biocartis to Collaborate with Medical College of Wisconsin on Breast Cancer Gene Signatures
24/03/2026
PRESS RELEASE - 03/24/2026, 08:00 EDT Biocartis to Collaborate with Medical College of Wisconsin on Breast Cancer Gene Signatures Itasca, IL, US, 24 March 2026 – Today, Biocartis announced that it has entered into a [...]
Immutrin raises £65 million ($87 million) Series A to develop next generation antibody therapy for ATTR amyloidosis
24/03/2026
Oversubscribed financing led by Frazier Life Sciences with participation from F-Prime, Qiming Venture Partners, SR One and founding investors Cambridge Innovation Capital and Cambridge Enterprise Ventures Proceeds will [...]
Lexicon Announces Three Presentations at the American College of Cardiology (ACC) Annual Scientific Session & Expo
24/03/2026
Additional analyses from the SCORED and SOTA-P-CARDIA studies provide further evidence of benefits across patient subgroups potentially related to sotagliflozin's mechanism of action THE WOODLANDS, Texas, March 24, 2026 [...]
Beacon Behavioral Partners Welcomes Novus Neurology and SunCoast Psychiatry
24/03/2026
Partnerships Expand Access to Advanced Neurological and Psychiatric Care in Florida and Alabama BATON ROUGE, La., March 24, 2026 (GLOBE NEWSWIRE) -- Beacon Behavioral Partners (BBP), a growing national network of [...]
MINES and Associates COO Recognized as 2026 Colorado Titan 100 Recipient
24/03/2026
LITTLETON, Colo., March 24, 2026 (GLOBE NEWSWIRE) -- MINES and Associates (MINES) is proud to announce that its Chief Operating Officer, Myron Unruh, has been named a 2026 Colorado Titan 100 recipient, an honor that [...]
Zymeworks Announces Participation in Upcoming Investor Conferences
24/03/2026
VANCOUVER, British Columbia, March 24, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets, while developing a diverse pipeline of novel, [...]
iDEL Therapeutics Appoints Claudia Ulbrich as Chair of its Board of Directors
24/03/2026
Dortmund, Germany, March 24, 2026 – iDEL Therapeutics today announced the appointment of accomplished biopharmaceutical executive Claudia Ulbrich, MD, as the Chair of its Board of Directors. Dr. Ulbrich brings over 25 [...]
Quotient Therapeutics Announces Collaboration with Merck to Discover Novel Drug Targets in Inflammatory Bowel Disease Using Somatic Genomics Platform Technology
24/03/2026
CAMBRIDGE, Mass., March 24, 2026 (GLOBE NEWSWIRE) -- Quotient Therapeutics, a company pioneering somatic genomics to inform breakthrough medicines, today announced that it has entered a multi-year research collaboration [...]
Compliance With Nasdaq Periodic Filing Requirement
24/03/2026
Singapore, March 24, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL) (the “Company”) today announced that it has received notification from Nasdaq that based on the Company’s amended annual report on [...]

Pages